NFL team doctors’ conservatism blamed for Maxx Crosby trade reversal

Updated March 13, 2026, 9:20 a.m. ET — A proposed trade that would have sent edge rusher Maxx Crosby from the Las Vegas Raiders to the Baltimore Ravens collapsed after the Ravens’ medical staff raised concerns during their review. The swap—reportedly centered on two first-round picks for 2026 and 2027—was announced, then voided days later when team physicians flagged Crosby’s January meniscus repair. The reversal echoes past high-profile cases in which team doctors scuttled deals, and it has prompted renewed debate over how conservative medical evaluations should be in the NFL.

Key takeaways

• The Ravens rescinded the Crosby trade announced in mid-March 2026 after their medical staff expressed concerns about a partial meniscus tear repaired surgically in January.
• Las Vegas had been prepared to send two first-round picks (2026, 2027) in exchange for Crosby before Baltimore backed out and returned him to the Raiders.
• Crosby had been asked to sit out the final two games of the Raiders’ season after the surgery; that decision reportedly contributed to tensions between player and team.
• Former Raiders CEO Amy Trask and others defended team physicians’ conservative stance; Mike Tannenbaum said nothing is final until 4 p.m. on the new league-year start date.
• The episode drew comparisons to the 2006 Dolphins passing on Drew Brees over a shoulder issue; in Brees’ case the player later became a Hall of Famer after signing with the Saints.
• Ravens GM Eric DeCosta called the decision agonizing and said he regretted the outcome but stood by the process used to gather medical information.
• Industry sources say similar physical-related reversals have occurred in the NFL, NBA and MLB, underscoring a persistent friction between risk-averse medical staffs and roster-building imperatives.

Background

Teams routinely condition trades on medical clearances; physicians review imaging, surgical reports and rehabilitation progress before a deal is finalized. The NFL’s calendar also injects formal timing: transactions tied to the new league year remain provisional until that year’s official start, when contracts and roster moves become binding. That procedural window has long been when clubs perform second-look physicals or when undisclosed issues surface, leading to modifications or cancellations.

Maxx Crosby, a four-time Pro Bowl edge rusher, underwent arthroscopic surgery in January to repair a partial meniscus tear. The Raiders limited his late-season participation and, according to reporting, Crosby chafed at being asked to miss the final two games—an episode that fed speculation about his standing in Las Vegas. Baltimore’s interest reflected Crosby’s on-field value; the initial willingness to exchange two first-round picks signaled that the Ravens viewed him as a near-elite upgrade to their pass rush.

Main event

The sequence began with Las Vegas and Baltimore agreeing terms on a trade that the Ravens announced publicly. Within days, the Raiders disclosed that Baltimore had “backed out” of the transaction. Team and league sources described the catalyst as a medical review that, in the Ravens’ assessment, raised enough doubt about Crosby’s near-term durability to alter the club’s valuation.

Ravens general manager Eric DeCosta addressed reporters, describing the choice as wrenching and saying the organization exhausted every channel to gather information. DeCosta framed the decision around what he judged to be best for Baltimore’s roster and long-term interests, acknowledging public skepticism while underscoring the limits of available medical certainty.

Voices around the league reacted rapidly. Former Raiders CEO Amy Trask defended team doctors’ conservatism—arguing few want to be the physician who underestimates risk—while Mike Tannenbaum noted that many medical red flags are actually flagged earlier, during pre-draft evaluations. One anonymous NFL general manager quoted on-air criticized Baltimore’s handling, but other executives emphasized the transactional nature of roster deals.

Analysis & implications

The Crosby episode highlights a persistent tension in professional sports: medical staffs are charged with minimizing long-term organizational risk, while general managers balance immediate competitive gains against future cost. When a team stakes premium assets—two first-round picks—on a single player, the margin for medical uncertainty narrows dramatically. Physicians, rewarded for caution and liable to professional scrutiny, often tip toward conservative judgments, particularly around surgical repairs that may complicate a high-value investment.

For the Raiders, the reversal resets a strategic problem: how to monetize or reconfigure a roster asset whose trade value was briefly pegged at top-tier draft capital. League sources say conditional trade structures—where compensation escalates if a player meets availability benchmarks—are common workarounds. Agents and front offices may increasingly prefer deals with performance or availability triggers to bridge medical disagreements.

For the Ravens, the public fallout is reputational but probably limited in practical terms. Multiple executives told analysts that organizations will continue to transact with Baltimore when the fit is right; trust between clubs is transactional and outcome-driven. Still, the optics of voiding a trade after announcement can generate short-term friction and media scrutiny that teams prefer to avoid.

Comparison & data

These examples show a pattern across leagues: medical evaluations can alter or halt transactions even after terms are agreed. While some players (like Brees) later defy early medical doubts, many transactions are shaped by differing risk tolerances between medical staffs and front offices. Quantifying how often announced trades are rescinded is difficult because clubs do not uniformly disclose every medical dispute; however, high-profile reversals form the basis for league-wide conversations about evaluation standards.

Reactions & quotes

Former Raiders CEO Amy Trask framed physicians’ caution as professionally rational. Her comments illuminate why team doctors often err on the side of restraint and how that can influence roster decisions.

“Team doctors have every reason to be extremely conservative—no one wants to stick their neck out and be wrong,”

Amy Trask, former Raiders CEO (CBS Sports analyst)

Mike Tannenbaum, now an ESPN analyst, emphasized the procedural nature of trades tied to the new league year and suggested alternative suitors might evaluate Crosby differently. His remarks underscore that medical judgments can vary across organizations.

“Nothing is official until 4 p.m. on the first day of the new league year—until then it’s hypotheticals,”

Mike Tannenbaum, former Jets GM (ESPN analyst)

Ravens GM Eric DeCosta described the choice as painful but deliberate, saying the team sought as much information as possible before deciding against the trade. His statement sought to place the decision within the frame of organizational duty and player welfare.

“Every decision we make is based on: ‘Is this the best thing for the Ravens?’ This was a really, really tough call,”

Eric DeCosta, Ravens GM (official statement)

Unconfirmed

• Precise medical details beyond the public description of a January partial meniscus repair have not been independently verified by all parties.
• Reports that Crosby left the Raiders “in a huff” after being asked to sit the final two games are based on secondary reporting and remain contested by those close to the team.
• Any internal Ravens communications about the timing or content of the medical review have not been publicly released and are not independently corroborated.

Bottom line

The Crosby trade reversal is a reminder that medical risk is a core constraint on NFL transactions: teams, physicians and executives operate with different incentives and tolerances for uncertainty. High-cost moves—particularly those involving multiple first-round selections—amplify those tensions and make conservatism more likely to prevail. For Crosby, the immediate impact is practical: he remains a Raiders player for now, and his market value may be reframed around availability-based conditions.

For the league, the episode will likely accelerate conversations about standardizing evaluation protocols or normalizing conditional deals that bridge medical disagreements. Fans and front offices should expect similar disputes in the future; how teams adapt—through contract language, insurance mechanisms or more transparent medical communication—will shape roster-building strategies in coming seasons.

Sources

• USA TODAY — reporting on trade reversal and medical review (media)
• ESPN — league-calendar and executive commentary referenced (media/analysis)
• FOX Sports — reporting on Crosby’s final Raiders days (media)
• CBS Sports — commentary from former Raiders CEO Amy Trask (media/analysis)
• NFL Network — on-air reactions and anonymous GM quote (league media)
• The Athletic — historical examples of medical-related trade reversals (media)